Acceder

Publicaciones - Metalofármacos antitumorales no convencionales

Cargando...
Novohradsky, Vojtech; Vigueras, Gloria; Pracharova, Jitka; Cutillas, Natalia; Janiak, Christoph; Kostrhunova, Hana; Brabec, Viktor; Ruiz, Jose; Kasparkova, Jana. Molecular superoxide radical photogeneration in cancer cells by dipyridophenazine iridium(III) complexes. INORGANIC CHEMISTRY FRONTIERS. SEP 1 2019; 6(9):2500-2513. 10.1039/c9qi00811j
AÑO: 2019; IF: 5.958
González JJ, Ortega E, Rothemund M, Gold M, Vicente C, de Haro C, Bautista D, Schobert R, Ruiz J. Luminescent Gold(I) Complexes of 1-Pyridyl-3-anthracenylchalcone Inducing Apoptosis in Colon Carcinoma Cells and Antivascular Effects. Inorg Chem. 2019 Oct 7;58(19):12954-12963. doi: 10.1021/acs.inorgchem.9b01901. Epub 2019 Sep 24. PubMed PMID: 31550148.
AÑO: 2019; IF: 4.825
Novohradsky V, Rovira A, Hally C, Galindo A, Vigueras G, Gandioso A, Svitelova M, Bresolí-Obach R, Kostrhunova H, Markova L, Kasparkova J, Nonell S, Ruiz J, Brabec V, Marchán V. Towards Novel Photodynamic Anticancer Agents Generating Superoxide Anion Radicals: A Cyclometalated Ir(III) Complex Conjugated to a Far-Red Emitting Coumarin. Angew Chem Int Ed Engl. 2019 May 6;58(19):6311-6315. doi: 10.1002/anie.201901268. Epub 2019 Apr 4. PubMed PMID: 30889300.
AÑO: 2019; IF: 12.959
Zamora A, Gandioso A, Massaguer A, Buenestado S, Calvis C, Hernández JL, Mitjans F, Rodríguez V, Ruiz J, Marchán V. Toward Angiogenesis Inhibitors Based on the Conjugation of Organometallic Platinum(II) Complexes to RGD Peptides. ChemMedChem. 2018 Sep 6;13(17):1755-1762. doi: 10.1002/cmdc.201800282. Epub 2018 Jul 18. PubMed PMID: 29932312.
AÑO: 2018; IF: 3.009
Pracharova J, Vigueras G, Novohradsky V, Cutillas N, Janiak C, Kostrhunova H, Kasparkova J, Ruiz J, Brabec V. Exploring the Effect of Polypyridyl Ligands on the Anticancer Activity of Phosphorescent Iridium(III) Complexes: From Proteosynthesis Inhibitors to Photodynamic Therapy Agents. Chemistry. 2018 Mar 26;24(18):4607-4619. doi: 10.1002/chem.201705362. Epub 2018 Feb 27. PubMed PMID: 29369444.
AÑO: 2018; IF: 5.16
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII

Metalofármacos antitumorales no convencionales